Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Mechanism of Cardiac Arrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 19, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Chunxia Yao1,2,3, Tina Veleva4, Larry Scott1,2,5
1Cardiovascular Research Institute (C.Y., L.S., S.C., P.J., X.P., Y.H.S., S.A.L., X.H.T.W., N.L.), Baylor College of Medicine, Houston, TX.
Cardiomyocyte NLRP3 inflammasome activation drives atrial fibrillation (AF) by causing electrical and structural changes. Inhibiting NLRP3 offers a potential new therapy for AF.
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: